Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Juan F Vesga"'
Autor:
Ntwali Placide Nsengiyumva, Jonathon R Campbell, Olivia Oxlade, Juan F Vesga, Christian Lienhardt, Anete Trajman, Dennis Falzon, Saskia Den Boon, Nimalan Arinaminpathy, Kevin Schwartzman
Publikováno v:
PLoS Medicine, Vol 19, Iss 6, p e1004032 (2022)
BackgroundShorter, safer, and cheaper tuberculosis (TB) preventive treatment (TPT) regimens will enhance uptake and effectiveness. WHO developed target product profiles describing minimum requirements and optimal targets for key attributes of novel T
Externí odkaz:
https://doaj.org/article/d15096b1f12447a894385e967b1b6ff5
Autor:
Juan F Vesga, Madeleine H A Clark, Edris Ayazi, Andrea Apolloni, Toby Leslie, W John Edmunds, Raphaёlle Métras
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 5, p e0010454 (2022)
BackgroundCrimean-Congo haemorrhagic fever virus (CCHFV) is a highly pathogenic virus for which a safe and effective vaccine is not yet available, despite being considered a priority emerging pathogen. Understanding transmission patterns and the use
Externí odkaz:
https://doaj.org/article/a5ae3349dca6429d997205ca7ad5575f
Autor:
Lucia Cilloni, Han Fu, Juan F Vesga, David Dowdy, Carel Pretorius, Sevim Ahmedov, Sreenivas A. Nair, Andrei Mosneaga, Enos Masini, Suvanand Sahu, Nimalan Arinaminpathy
Publikováno v:
EClinicalMedicine, Vol 28, Iss , Pp 100603- (2020)
Background: Routine services for tuberculosis (TB) are being disrupted by stringent lockdowns against the novel SARS-CoV-2 virus. We sought to estimate the potential long-term epidemiological impact of such disruptions on TB burden in high-burden cou
Externí odkaz:
https://doaj.org/article/f5b81c7a0c544676aad1853feee39f26
Autor:
Alexandra B Hogan, PhD, Britta L Jewell, PhD, Ellie Sherrard-Smith, PhD, Juan F Vesga, PhD, Oliver J Watson, PhD, Charles Whittaker, MSc, Arran Hamlet, PhD, Jennifer A Smith, DPhil, Peter Winskill, PhD, Robert Verity, PhD, Marc Baguelin, PhD, John A Lees, PhD, Lilith K Whittles, PhD, Kylie E C Ainslie, PhD, Samir Bhatt, DPhil, Adhiratha Boonyasiri, MD, Nicholas F Brazeau, PhD, Lorenzo Cattarino, PhD, Laura V Cooper, MPhil, Helen Coupland, MRes, Gina Cuomo-Dannenburg, MMath, Amy Dighe, MRes, Bimandra A Djaafara, MRes, Christl A Donnelly, ProfScD, Jeff W Eaton, PhD, Sabine L van Elsland, PhD, Richard G FitzJohn, PhD, Han Fu, PhD, Katy A M Gaythorpe, PhD, William Green, MRes, David J Haw, PhD, Sarah Hayes, MSc, Wes Hinsley, PhD, Natsuko Imai, PhD, Daniel J Laydon, PhD, Tara D Mangal, PhD, Thomas A Mellan, PhD, Swapnil Mishra, PhD, Gemma Nedjati-Gilani, PhD, Kris V Parag, PhD, Hayley A Thompson, MPH, H Juliette T Unwin, PhD, Michaela A C Vollmer, PhD, Caroline E Walters, PhD, Haowei Wang, MSc, Yuanrong Wang, Xiaoyue Xi, MSc, Neil M Ferguson, ProfDPhil, Lucy C Okell, PhD, Thomas S Churcher, PhD, Nimalan Arinaminpathy, DPhil, Azra C Ghani, ProfPhD, Patrick G T Walker, PhD, Timothy B Hallett, ProfPhD
Publikováno v:
The Lancet Global Health, Vol 8, Iss 9, Pp e1132-e1141 (2020)
Summary: Background: COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which di
Externí odkaz:
https://doaj.org/article/c3f23ef3c1124c1993c547ea5ad1e2a8
Autor:
Juan F Vesga, PhD, Timothy B Hallett, ProfPhD, Michael J A Reid, MD, Kuldeep Singh Sachdeva, MBA, Raghuram Rao, DPH, Sunil Khaparde, PhD, Paresh Dave, MPH, Kiran Rade, MD, Maureen Kamene, MSc, Eunice Omesa, MSc, Enos Masini, MPH, Newton Omale, MSc, Elizabeth Onyango, MSc, Philip Owiti, MSc, Muthoni Karanja, MSc, Richard Kiplimo, MSc, Sofia Alexandru, MPH, Valentina Vilc, MPH, Valeriu Crudu, PhD, Stela Bivol, MPH, Cristina Celan, MPH, Nimalan Arinaminpathy, DPhil
Publikováno v:
The Lancet Global Health, Vol 7, Iss 5, Pp e585-e595 (2019)
Summary: Background: In the context of WHO's End TB strategy, there is a need to focus future control efforts on those interventions and innovations that would be most effective in accelerating declines in tuberculosis burden. Using a modelling appro
Externí odkaz:
https://doaj.org/article/21b229fb15934ffb8f1d2e9f81e0b54e
Autor:
Mathieu Maheu-Giroux, Juan F Vesga, Souleymane Diabaté, Michel Alary, Stefan Baral, Daouda Diouf, Kouamé Abo, Marie-Claude Boily
Publikováno v:
PLoS Medicine, Vol 14, Iss 6, p e1002321 (2017)
BackgroundNational responses will need to be markedly accelerated to achieve the ambitious target of the Joint United Nations Programme on HIV/AIDS (UNAIDS). This target aims for 90% of HIV-positive individuals to be aware of their status, for 90% of
Externí odkaz:
https://doaj.org/article/e25bbbbe007040ea8ddf63b55a5a2bcb
Autor:
Marie-Claude Boily, Benoît Mâsse, Ramzi Alsallaq, Nancy S Padian, Jeffrey W Eaton, Juan F Vesga, Timothy B Hallett
Publikováno v:
PLoS Medicine, Vol 9, Iss 7, p e1001250 (2012)
The rigorous evaluation of the impact of combination HIV prevention packages at the population level will be critical for the future of HIV prevention. In this review, we discuss important considerations for the design and interpretation of cluster r
Externí odkaz:
https://doaj.org/article/34b732f07a4546c0ba4a468eedc6b4e6
Autor:
Juan F Vesga, Raphaёlle Métras, Madeleine H A Clark, Edris Ayazi, Andrea Apolloni, Toby Leslie, Veerle Msimang, Peter N. Thompson, W John Edmunds
Publikováno v:
Vaccine
Vaccine, 2022, 40 (40), pp.5806-5813. ⟨10.1016/j.vaccine.2022.08.061⟩
Vaccine, 2022, 40 (40), pp.5806-5813. ⟨10.1016/j.vaccine.2022.08.061⟩
BackgroundCrimean-Congo haemorrhagic fever (CCHF) is a priority emerging pathogen for which a licensed vaccine is not yet available. We aim to assess the feasibility of conducting phase III vaccine efficacy trials and the role of varying transmission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30dd7b5d158666ede091d1ba9a7ccc78
https://doi.org/10.1016/j.vaccine.2022.08.061
https://doi.org/10.1016/j.vaccine.2022.08.061
Autor:
Juan F. Vesga, Christian Lienhardt, Placide Nsengiyumva, Jonathon R. Campbell, Olivia Oxlade, Saskia den Boon, Dennis Falzon, Kevin Schwartzman, Gavin Churchyard, Nimalan Arinaminpathy
Publikováno v:
BMC Medicine
Background Recent years have seen important improvements in available preventive treatment regimens for tuberculosis (TB), and research is ongoing to develop these further. To assist with the formulation of target product profiles for future regimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a9d51f406329b18019c58ca292fcec6
http://hdl.handle.net/10044/1/97085
http://hdl.handle.net/10044/1/97085
Autor:
Marc Baguelin, Tara D. Mangal, Thomas A. Mellan, Neil M. Ferguson, Katy A. M. Gaythorpe, Laura V Cooper, Azra C. Ghani, Bimandra A Djaafara, Britta L Jewell, Lilith K Whittles, Kris V Parag, Ellie Sherrard-Smith, Jeff Eaton, D Haw, Oliver J Watson, Michaela A. C. Vollmer, John A. Lees, Thomas S. Churcher, Nicholas F Brazeau, Xiaoyue Xi, Jennifer A. Smith, William Green, Wes Hinsley, Amy Dighe, H. Juliette T. Unwin, Christl A. Donnelly, Gemma Nedjati-Gilani, Samir Bhatt, Kylie E. C. Ainslie, Caroline E. Walters, A Boonyasiri, Sarah Hayes, Hayley A Thompson, Richard G. FitzJohn, Swapnil Mishra, Sabine L. van Elsland, Juan F. Vesga, Daniel J Laydon, Peter Winskill, Charles Whittaker, Lucy C Okell, Timothy B. Hallett, Alexandra B. Hogan, Y Wang, Natsuko Imai, Patrick G T Walker, Gina Cuomo-Dannenburg, Arran Hamlet, Haowei Wang, Nimalan Arinaminpathy, Helen Coupland, Robert Verity, Lorenzo Cattarino, Han Fu
Publikováno v:
The Lancet Global Health, Vol 8, Iss 9, Pp e1132-e1141 (2020)
Summary Background COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b691d9f98984c50e2d83e21e7d57d55e
https://doi.org/10.1016/s2214-109x(20)30288-6
https://doi.org/10.1016/s2214-109x(20)30288-6